275 related articles for article (PubMed ID: 9271580)
1. Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
Speiser DE; Miranda R; Zakarian A; Bachmann MF; McKall-Faienza K; Odermatt B; Hanahan D; Zinkernagel RM; Ohashi PS
J Exp Med; 1997 Aug; 186(5):645-53. PubMed ID: 9271580
[TBL] [Abstract][Full Text] [Related]
2. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
3. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
4. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
[TBL] [Abstract][Full Text] [Related]
5. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
6. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
[TBL] [Abstract][Full Text] [Related]
7. Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.
Garza KM; McKall-Faienza KJ; Otheki T; Zakarian A; Odermatt B; Ohashi PS
Eur J Immunol; 2002 Mar; 32(3):885-94. PubMed ID: 11870633
[TBL] [Abstract][Full Text] [Related]
8. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
Rall GF; Mucke L; Oldstone MB
J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
[TBL] [Abstract][Full Text] [Related]
9. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.
Kägi D; Odermatt B; Ohashi PS; Zinkernagel RM; Hengartner H
J Exp Med; 1996 May; 183(5):2143-52. PubMed ID: 8642324
[TBL] [Abstract][Full Text] [Related]
10. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.
Zinkernagel RM; Pircher HP; Ohashi P; Oehen S; Odermatt B; Mak T; Arnheiter H; Bürki K; Hengartner H
Immunol Rev; 1991 Aug; 122():133-71. PubMed ID: 1937540
[TBL] [Abstract][Full Text] [Related]
11. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
Zeller JC; Nguyen N; Southern PJ
Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
[TBL] [Abstract][Full Text] [Related]
13. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
15. Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration.
McKall-Faienza KJ; Kawai K; Kündig TM; Odermatt B; Bachmann MF; Zakarian A; Mak TW; Ohashi PS
Int Immunol; 1998 Apr; 10(4):405-12. PubMed ID: 9620596
[TBL] [Abstract][Full Text] [Related]
16. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
18. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
19. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
Whitton JL; Gebhard JR; Lewicki H; Tishon A; Oldstone MB
J Virol; 1988 Mar; 62(3):687-95. PubMed ID: 2448497
[TBL] [Abstract][Full Text] [Related]
20. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
